175 related articles for article (PubMed ID: 33011064)
1. Poly-ICLC, a multi-functional immune modulator for treating cancer.
Sultan H; Salazar AM; Celis E
Semin Immunol; 2020 Jun; 49():101414. PubMed ID: 33011064
[TBL] [Abstract][Full Text] [Related]
2. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.
Saxena M; Sabado RL; La Mar M; Mohri H; Salazar AM; Dong H; Correa Da Rosa J; Markowitz M; Bhardwaj N; Miller E
Front Immunol; 2019; 10():725. PubMed ID: 31024557
[No Abstract] [Full Text] [Related]
3. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models.
Zhu X; Nishimura F; Sasaki K; Fujita M; Dusak JE; Eguchi J; Fellows-Mayle W; Storkus WJ; Walker PR; Salazar AM; Okada H
J Transl Med; 2007 Feb; 5():10. PubMed ID: 17295916
[TBL] [Abstract][Full Text] [Related]
4. Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.
Ammi R; De Waele J; Willemen Y; Van Brussel I; Schrijvers DM; Lion E; Smits EL
Pharmacol Ther; 2015 Feb; 146():120-31. PubMed ID: 25281915
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.
Dillon PM; Petroni GR; Smolkin ME; Brenin DR; Chianese-Bullock KA; Smith KT; Olson WC; Fanous IS; Nail CJ; Brenin CM; Hall EH; Slingluff CL
J Immunother Cancer; 2017 Nov; 5(1):92. PubMed ID: 29157306
[TBL] [Abstract][Full Text] [Related]
6. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans.
Caskey M; Lefebvre F; Filali-Mouhim A; Cameron MJ; Goulet JP; Haddad EK; Breton G; Trumpfheller C; Pollak S; Shimeliovich I; Duque-Alarcon A; Pan L; Nelkenbaum A; Salazar AM; Schlesinger SJ; Steinman RM; Sékaly RP
J Exp Med; 2011 Nov; 208(12):2357-66. PubMed ID: 22065672
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial.
Salazar AM; Erlich RB; Mark A; Bhardwaj N; Herberman RB
Cancer Immunol Res; 2014 Aug; 2(8):720-4. PubMed ID: 24801836
[TBL] [Abstract][Full Text] [Related]
8. Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients.
Ishikawa T; Kageyama S; Miyahara Y; Okayama T; Kokura S; Wang L; Sato E; Yagita H; Itoh Y; Shiku H
Cancer Immunol Immunother; 2021 Nov; 70(11):3081-3091. PubMed ID: 33751208
[TBL] [Abstract][Full Text] [Related]
9. Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice.
Sultan H; Wu J; Kumai T; Salazar AM; Celis E
Cancer Immunol Immunother; 2018 Jul; 67(7):1091-1103. PubMed ID: 29696308
[TBL] [Abstract][Full Text] [Related]
10. Double-Stranded RNA Immunomodulators in Prostate Cancer.
Salazar AM; Celis E
Urol Clin North Am; 2020 Nov; 47(4S):e1-e8. PubMed ID: 33446322
[TBL] [Abstract][Full Text] [Related]
11. A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy.
De Waele J; Verhezen T; van der Heijden S; Berneman ZN; Peeters M; Lardon F; Wouters A; Smits ELJM
J Exp Clin Cancer Res; 2021 Jun; 40(1):213. PubMed ID: 34172082
[TBL] [Abstract][Full Text] [Related]
12. Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trial.
Tsuji T; Sabbatini P; Jungbluth AA; Ritter E; Pan L; Ritter G; Ferran L; Spriggs D; Salazar AM; Gnjatic S
Cancer Immunol Res; 2013 Nov; 1(5):340-50. PubMed ID: 24777970
[TBL] [Abstract][Full Text] [Related]
13. Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys.
Puri SK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Jan; 16(1):49-52. PubMed ID: 8640451
[TBL] [Abstract][Full Text] [Related]
14. Brain tumor immunotherapy with type-1 polarizing strategies.
Okada H
Ann N Y Acad Sci; 2009 Sep; 1174():18-23. PubMed ID: 19769732
[TBL] [Abstract][Full Text] [Related]
15. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.
Kyi C; Roudko V; Sabado R; Saenger Y; Loging W; Mandeli J; Thin TH; Lehrer D; Donovan M; Posner M; Misiukiewicz K; Greenbaum B; Salazar A; Friedlander P; Bhardwaj N
Clin Cancer Res; 2018 Oct; 24(20):4937-4948. PubMed ID: 29950349
[No Abstract] [Full Text] [Related]
17. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury.
Gesuete R; Christensen SN; Bahjat FR; Packard AE; Stevens SL; Liu M; Salazar AM; Stenzel-Poore MP
Stroke; 2016 Jan; 47(1):262-6. PubMed ID: 26564103
[TBL] [Abstract][Full Text] [Related]
18. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.
Boukhvalova MS; Sotomayor TB; Point RC; Pletneva LM; Prince GA; Blanco JC
J Interferon Cytokine Res; 2010 Apr; 30(4):229-42. PubMed ID: 20038196
[TBL] [Abstract][Full Text] [Related]
19. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
Butowski N; Chang SM; Junck L; DeAngelis LM; Abrey L; Fink K; Cloughesy T; Lamborn KR; Salazar AM; Prados MD
J Neurooncol; 2009 Jan; 91(2):175-82. PubMed ID: 18797818
[TBL] [Abstract][Full Text] [Related]
20. Killing of Leishmania donovani amastigotes by poly ICLC in hamsters.
Bhakuni V; Singha UK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Apr; 16(4):321-5. PubMed ID: 9162526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
